GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

labetuzumab govitecan   Click here for help

GtoPdb Ligand ID: 8252

Synonyms: hMN-14-SN-38 | hMN-14-SN-38 ADC | IMMU 130 | IMMU-130
Compound class: Antibody
Comment: Labetuzumab govitecan (research code IMMU-130) is an antibody-drug conjugate (ADC) in which the anti-CEACAM5 antibody labetuzumab, is covalently bound to SN-38, the active metabolite of the topoisomerase inhibitor irinotecan (as exemplified in patents [2] and [1]).
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
10096 labetuzumab govitecan
Synonyms Click here for help
hMN-14-SN-38 | hMN-14-SN-38 ADC | IMMU 130 | IMMU-130
Database Links Click here for help
GtoPdb PubChem SID 249565932
Search PubMed clinical trials labetuzumab govitecan
Search PubMed titles labetuzumab govitecan
Search PubMed titles/abstracts labetuzumab govitecan